Free Trial

CompoSecure (CMPOW) Financials

$3.52 +0.08 (+2.33%)
As of 04/17/2025 03:58 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for CompoSecure

Annual Income Statements for CompoSecure

This table shows CompoSecure's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
81 78 3.15 19 19 -54
Consolidated Net Income / (Loss)
81 78 83 132 113 -83
Net Income / (Loss) Continuing Operations
81 78 83 132 113 -83
Total Pre-Tax Income
81 78 83 136 117 -81
Total Operating Income
87 84 81 115 119 108
Total Gross Profit
128 133 145 220 209 219
Total Revenue
243 261 268 378 391 421
Operating Revenue
243 261 268 378 391 421
Total Cost of Revenue
115 128 123 159 182 201
Operating Cost of Revenue
115 128 123 159 182 201
Total Operating Expenses
41 49 63 105 90 112
Selling, General & Admin Expense
41 49 63 105 90 112
Total Other Income / (Expense), net
-5.45 -6.14 1.13 21 -2.01 -189
Interest Expense
- - - 21 28 20
Interest & Investment Income
-4.75 -5.27 -10 1.25 4.98 4.65
Other Income / (Expense), net
-0.70 -0.88 11 41 21 -173
Income Tax Expense
0.00 0.00 -0.86 4.36 4.56 2.19
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 0.00 80 113 93 -29
Basic Earnings per Share
$0.00 $0.00 $0.21 $1.21 $1.03 ($1.22)
Weighted Average Basic Shares Outstanding
0.00 0.00 14.93M 15.37M 18.66M 44.01M
Diluted Earnings per Share
$0.00 $0.00 $0.12 $1.13 $0.96 ($1.22)
Weighted Average Diluted Shares Outstanding
0.00 0.00 94.57M 32.56M 35.31M 44.01M
Weighted Average Basic & Diluted Shares Outstanding
- - 76.07M 77.88M 80.53M 102.31M

Quarterly Income Statements for CompoSecure

This table shows CompoSecure's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
2.82 3.97 2.33 5.74 7.48 3.70 4.03 11 -42 -27
Consolidated Net Income / (Loss)
22 22 11 33 38 31 17 34 -85 -48
Net Income / (Loss) Continuing Operations
22 22 11 33 38 31 17 34 -85 -48
Total Pre-Tax Income
22 23 9.47 34 39 35 16 34 -85 -46
Total Operating Income
26 25 29 30 29 31 31 32 29 16
Total Gross Profit
62 50 53 54 49 53 55 56 55 53
Total Revenue
103 94 95 99 97 100 104 109 107 101
Operating Revenue
103 94 95 99 97 100 104 109 107 101
Total Cost of Revenue
42 44 42 45 48 47 49 52 52 48
Operating Cost of Revenue
42 44 42 45 48 47 49 52 52 48
Total Operating Expenses
36 25 24 24 20 22 24 24 26 37
Selling, General & Admin Expense
36 25 24 24 20 22 24 24 26 37
Total Other Income / (Expense), net
-3.36 -1.69 -20 3.33 10 4.40 -15 2.06 -114 -62
Interest & Investment Income
-5.30 16 -5.93 -5.44 -5.70 22 -5.42 -5.32 -5.14 21
Other Income / (Expense), net
1.94 3.90 -14 8.77 16 9.88 -9.48 7.38 -109 -62
Income Tax Expense
0.39 0.62 -1.26 0.97 0.95 3.90 -0.84 0.26 0.63 2.14
Net Income / (Loss) Attributable to Noncontrolling Interest
19 18 8.41 27 31 27 13 22 -43 -22
Basic Earnings per Share
$0.18 $0.24 $0.13 $0.31 $0.39 $0.20 $0.20 $0.44 ($1.10) ($0.76)
Weighted Average Basic Shares Outstanding
15.43M 15.37M 17.63M 18.54M 19.07M 18.66M 20.57M 25.44M 38.21M 44.01M
Diluted Earnings per Share
$0.18 $0.20 $0.11 $0.29 $0.34 $0.22 $0.17 $0.32 ($1.10) ($0.61)
Weighted Average Diluted Shares Outstanding
19.66M 32.56M 94.74M 35.53M 35.76M 35.31M 96.24M 96.64M 38.21M 44.01M
Weighted Average Basic & Diluted Shares Outstanding
76.35M 77.88M 78.39M 79.00M 79.32M 80.53M 80.59M 81.91M 88.13M 102.31M

Annual Cash Flow Statements for CompoSecure

This table details how cash moves in and out of CompoSecure's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
14 -13 8.52 -8.30 28 36
Net Cash From Operating Activities
81 87 78 93 104 130
Net Cash From Continuing Operating Activities
81 87 78 93 104 130
Net Income / (Loss) Continuing Operations
81 78 83 132 113 -83
Consolidated Net Income / (Loss)
81 78 83 132 113 -83
Depreciation Expense
8.61 9.92 10 8.58 8.39 9.17
Amortization Expense
0.67 0.84 1.65 2.35 1.55 1.16
Non-Cash Adjustments To Reconcile Net Income
1.21 3.01 3.23 -29 -5.77 193
Changes in Operating Assets and Liabilities, net
-11 -4.52 -21 -21 -12 9.48
Net Cash From Investing Activities
-9.64 -7.50 -4.75 -9.05 -11 -9.95
Net Cash From Continuing Investing Activities
-9.64 -7.50 -4.75 -9.05 -11 -9.95
Purchase of Property, Plant & Equipment
-9.64 -7.50 -4.75 -9.05 -11 -8.45
Other Investing Activities, net
- - - 0.00 0.00 -1.50
Net Cash From Financing Activities
-58 -93 -65 -92 -66 -83
Net Cash From Continuing Financing Activities
-58 -93 -65 -92 -66 -83
Repayment of Debt
-30 -14 -247 -32 -23 -15
Payment of Dividends
-104 -217 -241 -36 -38 -59
Issuance of Common Equity
0.00 0.00 61 0.08 1.20 5.00
Other Financing Activities, net
0.00 0.00 -15 -24 -5.56 -14
Cash Interest Paid
4.89 5.32 10 21 27 21
Cash Income Taxes Paid
- - 0.00 0.86 2.76 4.82

Quarterly Cash Flow Statements for CompoSecure

This table details how cash moves in and out of CompoSecure's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
2.04 -1.79 8.92 0.05 1.20 17 14 -20 17 25
Net Cash From Operating Activities
31 11 25 28 25 26 34 32 28 35
Net Cash From Continuing Operating Activities
31 11 25 28 25 26 34 32 28 35
Net Income / (Loss) Continuing Operations
22 22 11 33 38 31 17 34 -85 -48
Consolidated Net Income / (Loss)
22 22 11 33 38 31 17 34 -85 -48
Depreciation Expense
2.01 2.00 2.04 2.13 2.08 2.14 2.22 2.38 2.33 2.24
Amortization Expense
0.55 0.55 0.56 0.14 0.56 0.28 0.35 0.32 0.29 0.20
Non-Cash Adjustments To Reconcile Net Income
5.13 -21 15 -2.81 -1.03 -17 12 -1.01 80 102
Changes in Operating Assets and Liabilities, net
0.99 6.51 -3.93 -4.08 -15 10 2.02 -3.04 31 -20
Net Cash From Investing Activities
-3.72 -1.83 -3.67 -2.03 -0.97 -4.28 -1.61 -1.91 -1.98 -4.43
Net Cash From Continuing Investing Activities
-3.72 -1.83 -3.67 -2.03 -0.97 -4.28 -1.61 -1.91 -1.98 -4.43
Purchase of Property, Plant & Equipment
-3.72 -1.83 -3.67 -2.03 -0.97 -4.28 -1.61 -1.91 -1.98 -2.93
Net Cash From Financing Activities
-25 -11 -12 -26 -23 -4.76 -18 -50 -8.87 -6.20
Net Cash From Continuing Financing Activities
-25 -11 -12 -26 -23 -4.76 -18 -50 -8.87 -6.20
Repayment of Debt
-5.00 -10 -0.33 -4.69 -13 -4.69 -4.69 -4.69 -2.85 -2.70
Issuance of Common Equity
0.00 0.08 0.15 0.24 0.64 0.17 0.11 0.11 2.67 2.10
Other Financing Activities, net
- -0.11 -2.41 -2.27 -0.64 -0.24 -3.48 -21 16 -5.60
Cash Interest Paid
5.30 6.44 4.57 9.06 4.67 8.95 4.18 8.72 4.10 3.62

Annual Balance Sheets for CompoSecure

This table presents CompoSecure's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Total Assets
81 131 163 201 474
Total Current Assets
53 78 97 139 174
Cash & Equivalents
13 22 14 41 77
Accounts Receivable
8.79 28 37 40 47
Inventories, net
30 26 42 53 45
Prepaid Expenses
1.08 2.60 3.82 5.13 4.16
Plant, Property, & Equipment, net
28 22 23 25 23
Total Noncurrent Assets
0.01 31 43 36 277
Noncurrent Deferred & Refundable Income Taxes
0.00 26 26 24 265
Other Noncurrent Operating Assets
0.01 5.26 18 13 12
Total Liabilities & Shareholders' Equity
81 131 163 201 474
Total Liabilities
274 539 455 407 617
Total Current Liabilities
42 61 47 41 76
Short-Term Debt
24 13 14 10 11
Accounts Payable
2.42 7.06 7.13 5.19 12
Accrued Expenses
12 10 10 12 15
Current Deferred & Payable Income Tax Liabilities
- - 2.37 1.43 5.17
Other Current Liabilities
3.64 31 13 12 34
Total Noncurrent Liabilities
232 478 408 366 541
Long-Term Debt
232 375 344 326 184
Capital Lease Obligations
- - - 6.22 3.89
Noncurrent Deferred & Payable Income Tax Liabilities
- - 24 24 249
Other Noncurrent Operating Liabilities
0.41 103 39 9.51 104
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
0.00 608 600 597 0.00
Total Equity & Noncontrolling Interests
-193 -1,016 -892 -802 -143
Total Preferred & Common Equity
-193 -1,016 -892 -802 -143
Preferred Stock
- 0.00 0.00 0.00 0.00
Total Common Equity
-193 -1,016 -892 -802 -143
Common Stock
6.15 12 24 39 361
Retained Earnings
-199 -1,028 -925 -847 -507
Accumulated Other Comprehensive Income / (Loss)
- 0.00 8.28 4.99 2.54

Quarterly Balance Sheets for CompoSecure

This table presents CompoSecure's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
170 186 181 195 214 213 435
Total Current Assets
103 117 112 128 151 136 157
Cash & Equivalents
15 23 23 24 55 35 53
Accounts Receivable
46 39 37 49 35 40 44
Inventories, net
39 51 49 52 55 58 55
Prepaid Expenses
2.82 4.20 4.10 3.91 5.25 3.93 5.25
Plant, Property, & Equipment, net
23 24 24 23 25 24 23
Total Noncurrent Assets
44 44 45 44 38 53 256
Noncurrent Deferred & Refundable Income Taxes
25 28 28 28 26 41 245
Other Noncurrent Operating Assets
19 16 17 16 13 12 10
Total Liabilities & Shareholders' Equity
170 186 181 195 214 213 435
Total Liabilities
495 477 453 434 411 422 720
Total Current Liabilities
67 59 51 53 42 49 65
Short-Term Debt
9.69 19 19 10 12 13 10
Accounts Payable
13 15 6.64 14 4.75 9.43 9.69
Accrued Expenses
20 12 11 14 13 12 13
Current Deferred & Payable Income Tax Liabilities
- 2.37 1.67 1.67 1.43 1.43 0.12
Other Current Liabilities
24 10 13 13 11 13 31
Total Noncurrent Liabilities
428 418 402 381 369 373 656
Long-Term Debt
358 339 335 331 320 314 316
Noncurrent Deferred & Payable Income Tax Liabilities
- 25 24 24 24 43 234
Other Noncurrent Operating Liabilities
70 53 43 27 24 16 105
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
603 597 597 597 597 516 0.00
Total Equity & Noncontrolling Interests
-928 -888 -868 -835 -794 -726 -285
Total Preferred & Common Equity
-928 -888 -868 -835 -794 -726 -285
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-928 -888 -868 -835 -794 -726 -285
Common Stock
21 26 30 35 41 36 180
Retained Earnings
-958 -920 -907 -878 -840 -767 -468
Accumulated Other Comprehensive Income / (Loss)
9.00 6.63 7.91 7.65 5.44 4.85 2.57

Annual Metrics and Ratios for CompoSecure

This table displays calculated financial ratios and metrics derived from CompoSecure's official financial filings.

Metric 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - -
Revenue Growth
0.00% 7.11% 2.83% 41.25% 3.21% 7.67%
EBITDA Growth
0.00% -1.74% 11.76% 59.45% -10.56% -136.76%
EBIT Growth
0.00% -3.65% 11.69% 68.45% -10.67% -146.77%
NOPAT Growth
0.00% -3.41% -2.01% 35.18% 2.91% -34.18%
Net Income Growth
0.00% -4.49% 7.20% 58.03% -14.64% -173.91%
EPS Growth
0.00% 0.00% 0.00% 841.67% -15.04% -227.08%
Operating Cash Flow Growth
0.00% 7.24% -10.66% 19.29% 12.43% 24.20%
Free Cash Flow Firm Growth
0.00% 0.00% 411.78% -90.36% 323.34% 170.63%
Invested Capital Growth
0.00% 0.00% -184.28% 224.46% 82.80% -122.34%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 5.14% 1.59% 0.23%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 4.00% 8.35% -271.87%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 4.68% 9.10% -401.32%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 14.56% 2.16% 102.78%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 1.80% 8.35% -2,100.05%
EPS Q/Q Growth
0.00% 0.00% 0.00% 7.62% 2.13% -212.82%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% -16.93% 17.60% 7.45%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 16.56% 107.35%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 92.57% 22.36% -88.97%
Profitability Metrics
- - - - - -
Gross Margin
52.56% 50.90% 54.06% 58.03% 53.52% 52.13%
EBITDA Margin
39.25% 36.01% 39.14% 44.18% 38.29% -13.07%
Operating Margin
35.73% 32.22% 30.39% 30.36% 30.49% 25.59%
EBIT Margin
35.44% 31.88% 34.63% 41.30% 35.74% -15.53%
Profit (Net Income) Margin
33.49% 29.86% 31.13% 34.83% 28.80% -19.77%
Tax Burden Percent
100.00% 100.00% 101.04% 96.80% 96.11% 102.70%
Interest Burden Percent
94.49% 93.66% 88.97% 87.12% 83.85% 124.01%
Effective Tax Rate
0.00% 0.00% -1.04% 3.20% 3.89% 0.00%
Return on Invested Capital (ROIC)
0.00% 336.43% 2,097.13% 2,161.43% 154.60% 202.71%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 331.36% 2,097.50% 2,167.23% 154.00% 127.87%
Return on Net Nonoperating Assets (RNNOA)
0.00% -417.25% -2,124.92% -2,199.11% -199.81% -155.09%
Return on Equity (ROE)
0.00% -80.82% -27.80% -37.68% -45.21% 47.63%
Cash Return on Invested Capital (CROIC)
0.00% 136.43% 0.00% 32.08% 96.04% 0.00%
Operating Return on Assets (OROA)
0.00% 102.12% 87.25% 106.22% 76.72% -19.35%
Return on Assets (ROA)
0.00% 95.65% 78.43% 89.58% 61.83% -24.64%
Return on Common Equity (ROCE)
0.00% -80.82% -55.97% -102.77% -153.91% 128.99%
Return on Equity Simple (ROE_SIMPLE)
0.00% -40.41% -8.21% -14.77% -14.02% 57.97%
Net Operating Profit after Tax (NOPAT)
87 84 82 111 114 75
NOPAT Margin
35.73% 32.22% 30.70% 29.39% 29.30% 17.91%
Net Nonoperating Expense Percent (NNEP)
0.00% 5.07% -0.38% -5.80% 0.60% 74.84%
Return On Investment Capital (ROIC_SIMPLE)
- - - -20.82% -24.90% 134.33%
Cost of Revenue to Revenue
47.44% 49.10% 45.94% 41.97% 46.48% 47.87%
SG&A Expenses to Revenue
16.83% 18.68% 23.67% 27.68% 23.04% 26.54%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
16.83% 18.68% 23.67% 27.68% 23.04% 26.54%
Earnings before Interest and Taxes (EBIT)
86 83 93 156 140 -65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
96 94 105 167 150 -55
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.90 1.07 0.85 0.75 0.83 2.55
Price to Earnings (P/E)
2.70 3.59 71.94 15.25 16.90 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 2.46%
Earnings Yield
37.03% 27.85% 1.39% 6.56% 5.92% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 10.46 0.00 23.48 12.78 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 2.00 4.48 3.25 3.13 2.84
Enterprise Value to EBITDA (EV/EBITDA)
0.00 5.56 11.45 7.35 8.18 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 6.28 12.94 7.86 8.76 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 6.22 14.60 11.05 10.69 15.88
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 5.99 15.44 13.25 11.73 9.23
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 15.33 6.89 73.19 17.20 6.22
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 -1.33 -0.95 -1.23 -1.67 -1.39
Long-Term Debt to Equity
0.00 -1.20 -0.92 -1.18 -1.62 -1.31
Financial Leverage
0.00 -1.26 -1.01 -1.01 -1.30 -1.21
Leverage Ratio
0.00 -0.42 -0.35 -0.42 -0.73 -1.93
Compound Leverage Factor
0.00 -0.40 -0.32 -0.37 -0.61 -2.40
Debt to Total Capital
0.00% 404.03% -1,925.99% 542.43% 250.28% 355.78%
Short-Term Debt to Total Capital
0.00% 37.89% -62.12% 21.78% 7.53% 20.06%
Long-Term Debt to Total Capital
0.00% 366.14% -1,863.87% 520.66% 242.75% 335.72%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% -3,023.26% 909.47% 435.71% 0.00%
Common Equity to Total Capital
0.00% -304.03% 5,049.26% -1,351.91% -585.99% -255.78%
Debt to EBITDA
0.00 2.73 3.70 2.14 2.29 -3.63
Net Debt to EBITDA
0.00 2.58 3.49 2.06 2.02 -2.22
Long-Term Debt to EBITDA
0.00 2.47 3.58 2.05 2.22 -3.43
Debt to NOPAT
0.00 3.05 4.71 3.22 2.99 2.65
Net Debt to NOPAT
0.00 2.89 4.44 3.10 2.63 1.62
Long-Term Debt to NOPAT
0.00 2.76 4.56 3.09 2.90 2.50
Altman Z-Score
0.00 3.94 -6.17 -1.71 -0.60 0.23
Noncontrolling Interest Sharing Ratio
0.00% 0.00% -101.35% -172.74% -240.44% -170.83%
Liquidity Ratios
- - - - - -
Current Ratio
0.00 1.29 1.29 2.05 3.40 2.28
Quick Ratio
0.00 0.53 0.82 1.08 1.99 1.64
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 34 174 17 71 192
Operating Cash Flow to CapEx
842.00% 1,160.67% 1,638.85% 1,024.89% 953.14% 1,534.08%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.79 2.58 9.47
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 4.34 3.79 6.37
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 3.92 3.39 5.96
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 3.20 2.52 2.57 2.15 1.25
Accounts Receivable Turnover
0.00 29.64 14.60 11.61 10.05 9.57
Inventory Turnover
0.00 4.24 4.40 4.66 3.83 4.14
Fixed Asset Turnover
0.00 9.35 10.71 16.88 16.32 17.29
Accounts Payable Turnover
0.00 52.85 25.97 22.39 29.47 24.06
Days Sales Outstanding (DSO)
0.00 12.31 25.01 31.44 36.33 38.16
Days Inventory Outstanding (DIO)
0.00 86.14 83.03 78.34 95.41 88.26
Days Payable Outstanding (DPO)
0.00 6.91 14.05 16.30 12.38 15.17
Cash Conversion Cycle (CCC)
0.00 91.55 93.98 93.48 119.36 111.25
Capital & Investment Metrics
- - - - - -
Invested Capital
0.00 50 -42 52 96 -21
Invested Capital Turnover
0.00 10.44 68.30 73.55 5.28 11.32
Increase / (Decrease) in Invested Capital
0.00 50 -92 94 43 -117
Enterprise Value (EV)
0.00 522 1,201 1,229 1,223 1,196
Market Capitalization
220 279 227 285 325 1,074
Book Value per Share
$0.00 ($6.65) ($35.10) ($11.69) ($10.12) ($1.63)
Tangible Book Value per Share
$0.00 ($6.65) ($35.10) ($11.69) ($10.12) ($1.63)
Total Capital
0.00 63 -20 66 137 56
Total Debt
0.00 256 388 358 343 200
Total Long-Term Debt
0.00 232 375 344 332 188
Net Debt
0.00 242 366 344 301 122
Capital Expenditures (CapEx)
9.64 7.50 4.75 9.05 11 8.45
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 22 8.31 50 68 31
Debt-free Net Working Capital (DFNWC)
0.00 36 30 64 109 109
Net Working Capital (NWC)
0.00 12 18 50 98 98
Net Nonoperating Expense (NNE)
5.45 6.14 -1.14 -21 1.93 158
Net Nonoperating Obligations (NNO)
0.00 242 366 344 301 122
Total Depreciation and Amortization (D&A)
9.28 11 12 11 9.93 10
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 8.62% 3.10% 13.34% 17.28% 7.46%
Debt-free Net Working Capital to Revenue
0.00% 13.77% 11.29% 16.94% 27.83% 25.88%
Net Working Capital to Revenue
0.00% 4.56% 6.63% 13.15% 25.19% 23.20%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.91 $1.21 $1.03 ($1.22)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 14.93M 15.37M 18.66M 44.01M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.14 $1.13 $0.96 ($1.22)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 94.93M 32.56M 35.31M 44.01M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 76.07M 77.88M 80.53M 102.31M
Normalized Net Operating Profit after Tax (NOPAT)
61 59 57 111 114 75
Normalized NOPAT Margin
25.01% 22.55% 21.27% 29.39% 29.30% 17.91%
Pre Tax Income Margin
33.49% 29.86% 30.81% 35.98% 29.97% -19.25%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 7.31 5.07 -3.21
NOPAT to Interest Expense
0.00 0.00 0.00 5.20 4.16 3.71
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 6.89 4.68 -3.63
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 4.78 3.76 3.29
Payout Ratios
- - - - - -
Dividend Payout Ratio
127.41% 278.44% 288.48% 27.53% 34.09% -71.38%
Augmented Payout Ratio
127.41% 278.44% 288.48% 27.53% 34.09% -71.38%

Quarterly Metrics and Ratios for CompoSecure

This table displays calculated financial ratios and metrics derived from CompoSecure's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
56.09% 24.55% 13.22% 1.37% -6.21% 6.52% 9.12% 10.19% 10.58% 0.96%
EBITDA Growth
24.42% 25.89% -48.20% -41.72% 57.04% 36.82% 34.55% 1.16% -262.55% -203.03%
EBIT Growth
30.17% 32.14% -51.54% -42.62% 62.02% 40.51% 40.60% 0.13% -278.01% -215.25%
NOPAT Growth
16.64% 151.59% 13.41% -10.41% 11.55% 12.15% -1.77% 7.04% -27.53% -59.73%
Net Income Growth
17.12% 11.67% -60.10% -46.07% 73.79% 38.78% 59.01% 2.71% -324.64% -255.87%
EPS Growth
0.00% 66.67% -52.17% -44.23% 88.89% 10.00% 54.55% 10.34% -423.53% -377.27%
Operating Cash Flow Growth
46.69% -63.60% 109.06% -28.87% -18.55% 144.25% 35.56% 14.83% 13.01% 33.99%
Free Cash Flow Firm Growth
0.00% 0.00% -103.47% -98.03% -112.26% 76.89% 71.13% 100.43% 579.24% 888.57%
Invested Capital Growth
-85.62% 224.46% 1,406.57% 77.10% 187.70% 82.80% 78.90% 40.73% -114.46% -122.34%
Revenue Q/Q Growth
6.28% -9.21% 1.63% 3.37% -1.67% 3.11% 4.11% 4.38% -1.32% -5.86%
EBITDA Q/Q Growth
-57.56% 3.85% -42.49% 129.94% 14.35% -9.52% -43.44% 72.88% -283.74% 42.65%
EBIT Q/Q Growth
-59.54% 4.24% -46.44% 153.99% 14.24% -9.60% -46.40% 80.88% -303.11% 41.47%
NOPAT Q/Q Growth
-23.43% -4.01% 37.85% -11.57% -4.66% -3.50% 20.73% -3.63% -35.46% -46.37%
Net Income Q/Q Growth
-63.91% 2.11% -51.97% 204.65% 16.32% -18.46% -44.97% 96.78% -354.41% 43.42%
EPS Q/Q Growth
-65.38% 11.11% -45.00% 163.64% 17.24% -35.29% -22.73% 88.24% -443.75% 44.55%
Operating Cash Flow Q/Q Growth
-22.57% -64.60% 130.06% 12.80% -11.34% 6.17% 27.69% -4.45% -12.75% 25.88%
Free Cash Flow Firm Q/Q Growth
-0.70% -137.56% 88.30% 145.23% -716.79% 29.21% 76.30% 414.04% 1,374.81% 16.48%
Invested Capital Q/Q Growth
-18.61% 92.57% -15.00% 32.94% 32.21% 22.36% -11.03% 4.58% -113.59% -88.97%
Profitability Metrics
- - - - - - - - - -
Gross Margin
59.78% 53.60% 55.98% 54.74% 50.47% 52.95% 53.08% 51.65% 51.72% 52.09%
EBITDA Margin
29.18% 33.37% 18.89% 42.01% 48.86% 42.87% 23.29% 38.57% -71.82% -43.75%
Operating Margin
24.82% 26.50% 30.86% 30.80% 29.73% 30.56% 29.94% 29.28% 27.15% 15.47%
EBIT Margin
26.70% 30.66% 16.16% 39.71% 46.13% 40.45% 20.82% 36.08% -74.26% -46.17%
Profit (Net Income) Margin
21.19% 23.84% 11.26% 33.20% 39.27% 31.06% 16.41% 30.95% -79.78% -47.95%
Tax Burden Percent
98.24% 97.29% 113.33% 97.12% 97.57% 88.83% 105.15% 99.24% 100.74% 104.62%
Interest Burden Percent
80.79% 79.90% 61.51% 86.09% 87.26% 86.43% 74.98% 86.43% 106.64% 99.26%
Effective Tax Rate
1.76% 2.71% -13.33% 2.88% 2.43% 11.17% -5.15% 0.76% 0.00% 0.00%
Return on Invested Capital (ROIC)
81.19% 1,896.28% 574.15% 252.68% 211.60% 143.23% 202.54% 167.06% 238.43% 122.53%
ROIC Less NNEP Spread (ROIC-NNEP)
79.32% 1,895.76% 567.84% 253.60% 214.58% 144.44% 197.42% 167.71% 202.59% 94.54%
Return on Net Nonoperating Assets (RNNOA)
-205.63% -1,923.65% -608.19% -292.28% -254.70% -187.41% -247.58% -217.37% -228.47% -114.67%
Return on Equity (ROE)
-124.44% -27.37% -34.04% -39.60% -43.10% -44.17% -45.05% -50.31% 9.96% 7.87%
Cash Return on Invested Capital (CROIC)
0.00% 32.08% 296.27% 180.61% 115.74% 96.04% 130.26% 131.93% 0.00% 0.00%
Operating Return on Assets (OROA)
47.32% 78.86% 38.24% 93.25% 97.24% 86.81% 41.64% 74.89% -98.85% -57.54%
Return on Assets (ROA)
37.55% 61.31% 26.66% 77.97% 82.78% 66.66% 32.83% 64.24% -106.19% -59.75%
Return on Common Equity (ROCE)
-893.37% -74.65% -95.46% -118.11% -134.81% -150.38% -155.06% -166.74% 21.29% 21.31%
Return on Equity Simple (ROE_SIMPLE)
-13.96% 0.00% -13.03% -10.10% -12.43% 0.00% -14.97% -16.50% 1.33% 0.00%
Net Operating Profit after Tax (NOPAT)
25 24 33 29 28 27 33 32 20 11
NOPAT Margin
24.38% 25.78% 34.97% 29.92% 29.00% 27.15% 31.48% 29.06% 19.01% 10.83%
Net Nonoperating Expense Percent (NNEP)
1.87% 0.51% 6.32% -0.92% -2.97% -1.21% 5.11% -0.66% 35.83% 27.99%
Return On Investment Capital (ROIC_SIMPLE)
- -4.53% - - - -5.90% - - - 19.47%
Cost of Revenue to Revenue
40.22% 46.40% 44.02% 45.26% 49.53% 47.05% 46.92% 48.35% 48.28% 47.91%
SG&A Expenses to Revenue
34.96% 27.11% 25.12% 23.94% 20.74% 22.39% 23.15% 22.36% 24.56% 36.62%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
34.96% 27.11% 25.12% 23.94% 20.74% 22.39% 23.15% 22.36% 24.56% 36.62%
Earnings before Interest and Taxes (EBIT)
28 29 15 39 45 40 22 39 -80 -47
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
30 31 18 41 47 43 24 42 -77 -44
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.01 0.75 1.40 1.31 1.27 0.83 1.39 1.34 2.74 2.55
Price to Earnings (P/E)
0.00 15.25 31.11 34.56 24.93 16.90 26.55 20.84 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.41% 2.14% 2.46%
Earnings Yield
0.00% 6.56% 3.21% 2.89% 4.01% 5.92% 3.77% 4.80% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
48.51 23.48 33.24 24.36 17.90 12.78 17.95 16.30 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
3.66 3.25 3.80 3.69 3.64 3.13 3.58 3.31 3.39 2.84
Enterprise Value to EBITDA (EV/EBITDA)
8.20 7.35 9.83 11.93 10.14 8.18 9.18 8.68 44.46 0.00
Enterprise Value to EBIT (EV/EBIT)
8.83 7.86 10.57 13.00 10.94 8.76 9.80 9.30 65.62 0.00
Enterprise Value to NOPAT (EV/NOPAT)
13.59 11.05 13.23 13.18 12.50 10.69 12.33 11.49 0.00 15.88
Enterprise Value to Operating Cash Flow (EV/OCF)
11.81 13.25 13.99 15.27 15.79 11.73 12.63 11.56 11.79 9.23
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 73.19 21.05 17.24 22.95 17.20 17.68 14.44 0.00 6.22
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
-1.13 -1.23 -1.23 -1.30 -1.43 -1.67 -1.68 -1.57 -1.15 -1.39
Long-Term Debt to Equity
-1.10 -1.18 -1.17 -1.23 -1.38 -1.62 -1.62 -1.50 -1.11 -1.31
Financial Leverage
-2.59 -1.01 -1.07 -1.15 -1.19 -1.30 -1.25 -1.30 -1.13 -1.21
Leverage Ratio
-2.99 -0.42 -0.49 -0.55 -0.65 -0.73 -0.82 -0.82 -1.20 -1.93
Compound Leverage Factor
-2.42 -0.34 -0.30 -0.47 -0.56 -0.63 -0.61 -0.71 -1.28 -1.92
Debt to Total Capital
862.19% 542.43% 534.11% 432.49% 334.07% 250.28% 246.46% 276.24% 789.09% 355.78%
Short-Term Debt to Total Capital
22.73% 21.78% 27.96% 22.93% 10.13% 7.53% 8.81% 11.32% 24.18% 20.06%
Long-Term Debt to Total Capital
839.47% 520.66% 506.15% 409.56% 323.95% 242.75% 237.65% 264.92% 764.92% 335.72%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1,414.52% 909.47% 889.50% 729.53% 584.68% 435.71% 442.70% 435.29% 0.00% 0.00%
Common Equity to Total Capital
-2,176.71% -1,351.91% -1,323.61% -1,062.02% -818.75% -585.99% -589.16% -611.54% -689.09% -255.78%
Debt to EBITDA
2.29 2.14 2.38 2.93 2.47 2.29 2.13 2.10 10.20 -3.63
Net Debt to EBITDA
2.19 2.06 2.23 2.74 2.30 2.02 1.78 1.87 8.56 -2.22
Long-Term Debt to EBITDA
2.23 2.05 2.26 2.77 2.39 2.22 2.06 2.01 9.89 -3.43
Debt to NOPAT
3.78 3.22 3.20 3.23 3.04 2.99 2.86 2.78 -0.12 2.65
Net Debt to NOPAT
3.63 3.10 3.00 3.03 2.83 2.63 2.39 2.48 -0.10 1.62
Long-Term Debt to NOPAT
3.69 3.09 3.04 3.06 2.95 2.90 2.76 2.66 -0.12 2.50
Altman Z-Score
-4.54 -4.30 -3.50 -3.05 -2.44 -2.22 -1.88 -1.24 0.07 0.36
Noncontrolling Interest Sharing Ratio
-617.92% -172.74% -180.44% -198.25% -212.79% -240.44% -244.24% -231.40% -113.88% -170.83%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.54 2.05 1.98 2.21 2.43 3.40 3.56 2.79 2.43 2.28
Quick Ratio
0.91 1.08 1.04 1.16 1.37 1.99 2.13 1.53 1.49 1.64
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
187 -70 -8.22 3.72 -23 -16 -2.37 7.45 110 128
Operating Cash Flow to CapEx
822.44% 590.72% 679.13% 1,382.77% 2,561.52% 618.32% 2,092.44% 1,684.90% 1,418.15% 1,207.12%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 742.56 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 190.11 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 176.70 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
1.77 2.57 2.37 2.35 2.11 2.15 2.00 2.08 1.33 1.25
Accounts Receivable Turnover
0.00 11.61 10.02 9.57 8.15 10.05 10.75 10.75 9.09 9.57
Inventory Turnover
0.00 4.66 4.21 4.42 3.91 3.83 3.54 3.69 3.74 4.14
Fixed Asset Turnover
0.00 16.88 17.12 17.26 16.76 16.32 16.34 17.08 18.19 17.29
Accounts Payable Turnover
20.05 22.39 16.29 25.44 13.34 29.47 18.61 24.44 16.84 24.06
Days Sales Outstanding (DSO)
0.00 31.44 36.43 38.16 44.77 36.33 33.96 33.96 40.16 38.16
Days Inventory Outstanding (DIO)
0.00 78.34 86.60 82.56 93.39 95.41 103.15 98.93 97.70 88.26
Days Payable Outstanding (DPO)
18.20 16.30 22.41 14.35 27.36 12.38 19.61 14.94 21.68 15.17
Cash Conversion Cycle (CCC)
-18.20 93.48 100.62 106.37 110.80 119.36 117.49 117.95 116.18 111.25
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
27 52 45 59 78 96 80 83 -11 -21
Invested Capital Turnover
3.33 73.55 16.42 8.45 7.30 5.28 6.43 5.75 12.54 11.32
Increase / (Decrease) in Invested Capital
-162 94 42 26 51 43 35 24 -90 -117
Enterprise Value (EV)
1,319 1,229 1,480 1,441 1,400 1,223 1,429 1,357 1,422 1,196
Market Capitalization
364 285 547 513 487 325 556 548 1,148 1,074
Book Value per Share
($12.19) ($11.69) ($11.40) ($11.08) ($10.57) ($10.12) ($9.86) ($9.00) ($3.48) ($1.63)
Tangible Book Value per Share
($12.19) ($11.69) ($11.40) ($11.08) ($10.57) ($10.12) ($9.86) ($9.00) ($3.48) ($1.63)
Total Capital
43 66 67 82 102 137 135 119 41 56
Total Debt
367 358 358 354 341 343 332 328 326 200
Total Long-Term Debt
358 344 339 335 331 332 320 314 316 188
Net Debt
352 344 336 331 317 301 277 292 274 122
Capital Expenditures (CapEx)
3.72 1.83 3.67 2.03 0.97 4.28 1.61 1.91 1.98 2.93
Debt-free, Cash-free Net Working Capital (DFCFNWC)
30 50 54 57 62 68 65 66 50 31
Debt-free Net Working Capital (DFNWC)
46 64 77 80 86 109 120 101 102 109
Net Working Capital (NWC)
36 50 58 61 75 98 108 87 92 98
Net Nonoperating Expense (NNE)
3.30 1.82 23 -3.24 -9.95 -3.91 16 -2.05 106 59
Net Nonoperating Obligations (NNO)
352 344 336 331 317 301 277 292 274 122
Total Depreciation and Amortization (D&A)
2.56 2.55 2.60 2.27 2.64 2.42 2.57 2.70 2.62 2.44
Debt-free, Cash-free Net Working Capital to Revenue
8.47% 13.34% 13.94% 14.69% 16.10% 17.28% 16.30% 16.01% 11.81% 7.46%
Debt-free Net Working Capital to Revenue
12.76% 16.94% 19.73% 20.47% 22.29% 27.83% 30.11% 24.66% 24.36% 25.88%
Net Working Capital to Revenue
10.07% 13.15% 14.92% 15.68% 19.60% 25.19% 27.13% 21.37% 21.98% 23.20%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.18 $0.24 $0.13 $0.31 $0.39 $0.20 $0.20 $0.44 ($1.10) ($0.76)
Adjusted Weighted Average Basic Shares Outstanding
15.43M 15.37M 17.63M 18.54M 19.07M 18.66M 20.57M 25.44M 38.21M 44.01M
Adjusted Diluted Earnings per Share
$0.18 $0.20 $0.11 $0.29 $0.34 $0.22 $0.17 $0.32 ($1.10) ($0.61)
Adjusted Weighted Average Diluted Shares Outstanding
19.66M 32.56M 94.74M 35.53M 35.76M 35.31M 96.24M 96.64M 38.21M 44.01M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
76.35M 77.88M 78.39M 79.00M 79.32M 80.53M 80.59M 81.91M 88.13M 102.31M
Normalized Net Operating Profit after Tax (NOPAT)
25 24 21 29 28 27 22 32 20 11
Normalized NOPAT Margin
24.38% 25.78% 21.60% 29.92% 29.00% 27.15% 20.95% 29.06% 19.01% 10.83%
Pre Tax Income Margin
21.57% 24.50% 9.94% 34.18% 40.25% 34.96% 15.61% 31.18% -79.19% -45.83%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -537.57 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 137.60 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -550.98 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 124.19 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
196.05% 27.53% 39.78% 45.12% 37.66% 34.09% 32.64% 37.12% -1,570.32% -71.38%
Augmented Payout Ratio
196.05% 27.53% 39.78% 45.12% 37.66% 34.09% 32.64% 37.12% -1,570.32% -71.38%

Frequently Asked Questions About CompoSecure's Financials

When does CompoSecure's financial year end?

According to the most recent income statement we have on file, CompoSecure's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has CompoSecure's net income changed over the last 5 years?

CompoSecure's net income appears to be on a downward trend, with a most recent value of -$83.16 million in 2024, falling from $81.47 million in 2019. The previous period was $112.52 million in 2023.

What is CompoSecure's operating income?
CompoSecure's total operating income in 2024 was $107.62 million, based on the following breakdown:
  • Total Gross Profit: $219.23 million
  • Total Operating Expenses: $111.61 million
How has CompoSecure revenue changed over the last 5 years?

Over the last 5 years, CompoSecure's total revenue changed from $243.29 million in 2019 to $420.57 million in 2024, a change of 72.9%.

How much debt does CompoSecure have?

CompoSecure's total liabilities were at $617.36 million at the end of 2024, a 51.8% increase from 2023, and a 125.4% increase since 2020.

How much cash does CompoSecure have?

In the past 4 years, CompoSecure's cash and equivalents has ranged from $13.42 million in 2020 to $77.46 million in 2024, and is currently $77.46 million as of their latest financial filing in 2024.

How has CompoSecure's book value per share changed over the last 5 years?

Over the last 5 years, CompoSecure's book value per share changed from 0.00 in 2019 to -1.63 in 2024, a change of -162.8%.



This page (NASDAQ:CMPOW) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners